COMMUNIQUÉS West-GlobeNewswire

Alliqua BioMedical, Inc. Reports Third Quarter of Fiscal Year 2017 Financial Results and Increases Fiscal Year 2017 Financial Outlook

09/11/2017 - 13:02

YARDLEY, Pa., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq: ALQA ) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding lives, today [...]

Alliqua BioMedical, Inc. Engages Cowen to Assist in Evaluating Potential Strategic Alternatives

09/11/2017 - 13:01

YARDLEY, Pa., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq: ALQA ) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding lives, today [...]

Summit Highlights Utrophin Modulation as a Potential Universal Treatment Option in DMD at Action Duchenne

09/11/2017 - 13:00

Summit Therapeutics plc ("Summit" or the "Company") SUMMIT HIGHLIGHTS UTROPHIN MODULATION AS A POTENTIAL UNIVERSAL TREATMENT OPTION IN DMD AT 15th ACTION DUCHENNE INTERNATIONAL CONFERENCE New Preclinical Data Show [...]

Sanofi, Principia agree to develop multiple sclerosis drug candidate

09/11/2017 - 13:00

Sanofi, Principia agree to develop multiple sclerosis drug candidate Clinical-stage oral drug candidate (PRN2246) with the potential to treat multiple sclerosis Principia to receive $40 million upfront payment, future [...]

Accord entre Sanofi et Principia pour le développement d'un candidat-médicament contre la sclérose en plaques

09/11/2017 - 13:00

Accord entre Sanofi et Principia pour le développement d'un candidat-médicament contre la sclérose en plaques L'accord porte sur un candidat-médicament par voie orale au stade du développement clinique (PRN2246) dans le [...]

2017 HomeCare Elite Recognizes Top Amedisys Care Centers Nationwide

09/11/2017 - 13:00

BATON ROUGE, La., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Amedisys (NASDAQ: AMED ), a leading healthcare at home company, today announced that 48 percent of its home health care centers across the country have been named to [...]

Natus to Present at 29th Annual Piper Jaffray Healthcare Conference

09/11/2017 - 13:00

PLEASANTON, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) today announced that Jonathan Kennedy, Executive Vice President and Chief Financial Officer, will present at the 29 th [...]

Athenex, Inc. Announces Third Quarter 2017 Results

09/11/2017 - 13:00

Encouraging results of 1 st interim analysis of the Oraxol Phase III clinical trial for breast cancer Commencement of the KX-01 ointment Phase III clinical trials for Actinic Keratosis Launched Oxaliplatin Injection, [...]

ContraFect Announces Third Quarter 2017 Financial Results

09/11/2017 - 13:00

YONKERS, N.Y., Nov. 09, 2017 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ: CFRX ), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug- [...]

Codexis to Present at Two Investment Conferences in November

09/11/2017 - 13:00

REDWOOD CITY, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS ), a leading protein engineering company, announces that management will present at two investment conferences in November: 8th Annual [...]

Nabriva Therapeutics Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights

09/11/2017 - 13:00

- Positive topline results from pivotal LEAP 1 trial announced in September, with read-out from second Phase 3 trial, LEAP 2, expected in the spring of 2018 - - $112.7 million cash and investments as of September 30, [...]

BeyondSpring Reports Third Quarter 2017 Operational and Financial Results

09/11/2017 - 13:00

NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ) (“BeyondSpring” or the “Company”), a late-stage clinical biopharmaceutical company focusing on the development of a pipeline of innovative [...]

Onconova Therapeutics, Inc. Reports Business Highlights and Third Quarter 2017 Financial Results

09/11/2017 - 13:00

NEWTOWN, Pa., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat [...]

TearLab Corporation Begins Trading on OTCQB

09/11/2017 - 13:00

SAN DIEGO, Nov. 09, 2017 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB:TEAR) (TSX: TLB ) (“TearLab” or the “Company”), today announced that shares of its common stock will begin trading on the OTCQB Market, which is [...]

Recro Pharma Reports Third Quarter 2017 Financial Results

09/11/2017 - 13:00

NDA Submission for IV Meloxicam Accepted by U.S. FDA for Review; PDUFA Date Set for May 26, 2018 Strong Gainesville Manufacturing Performance; Third Quarter 2017 Revenues of $17.1 Million MALVERN, Pa., Nov. 09, 2017 ( [...]

RedHill Biopharma Announces Last Patient Enrolled in the Phase III Study with RHB-104 for Crohn’s Disease

09/11/2017 - 13:00

Top-line results are expected to be announced in mid-2018 The Phase III study evaluating RHB-104 for Crohn’s disease (MAP US study) is a randomized, double-blind, placebo-controlled study that is evaluating the safety [...]

Summit Highlights Utrophin Modulation as a Potential Universal Treatment Option in DMD at 15th Action Duchenne International Conference

09/11/2017 - 13:00

New Preclinical Data Show Utrophin’s Positive Effect on Mitochondria Improving Muscle Health in DMD Model OXFORD, United Kingdom, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT ) (AIM:SUMM) the [...]

Alcobra Announces Third Quarter 2017 Financial Results and Provides Corporate Update

09/11/2017 - 13:00

TEL AVIV, Israel, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Alcobra Ltd. (NasdaqGM:ADHD) today announced financial results for the three and nine months ended September 30, 2017, and provided a corporate update. Third Quarter [...]

ProQR Appoints Thaddeus Dryja, M.D. to Scientific Advisory Board

09/11/2017 - 13:00

Key Updates Dr. Thaddeus (Ted) Dryja, a pioneer in the field of retinal genetic diseases, joins the Company’s Scientific Advisory Board. Dr. Dryja will play a key strategic role in the development and advancement of [...]